Eagle Net Invested Capital from 2010 to 2024

EGRX Stock  USD 4.73  0.02  0.42%   
Eagle Pharmaceuticals Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital will likely drop to about 250.6 M in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
340.4 M
Current Value
250.6 M
Quarterly Volatility
36 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Eagle Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eagle main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.5 M, Interest Expense of 4.9 M or Selling General Administrative of 118.5 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Ptb Ratio of 1.77 or Days Sales Outstanding of 129. Eagle financial statements analysis is a perfect complement when working with Eagle Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Eagle Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Eagle Pharmaceuticals Technical models . Check out the analysis of Eagle Pharmaceuticals Correlation against competitors.
For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.

Latest Eagle Pharmaceuticals' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Eagle Pharmaceuticals over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Eagle Pharmaceuticals' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Eagle Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

Eagle Net Invested Capital Regression Statistics

Arithmetic Mean236,438,564
Geometric Mean234,267,109
Coefficient Of Variation15.21
Mean Deviation23,702,236
Median226,924,000
Standard Deviation35,955,506
Sample Variance1292.8T
Range138.4M
R-Value0.46
Mean Square Error1101.1T
R-Squared0.21
Significance0.09
Slope3,676,894
Total Sum of Squares18099.2T

Eagle Net Invested Capital History

2024250.6 M
2023340.4 M
2022296 M
2021202.1 M
2020219.1 M
2019217.7 M
2018205.2 M

About Eagle Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Eagle Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Eagle Pharmaceuticals investors use historical funamental indicators, such as Eagle Pharmaceuticals's Net Invested Capital, to determine how well the company is positioned to perform in the future. Although Eagle Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Eagle Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Eagle Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Eagle Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Eagle Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital340.4 M250.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Eagle Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eagle Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eagle Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eagle Pharmaceuticals Stock:
Check out the analysis of Eagle Pharmaceuticals Correlation against competitors.
For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Eagle Stock analysis

When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Eagle Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.87)
Earnings Share
0.85
Revenue Per Share
19.684
Quarterly Revenue Growth
(0.13)
Return On Assets
0.0663
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.